Data from a recently published study has identified alcohol consumption as a predictor for advanced liver disease among patients with T2D. Patients enrolled in a diabetes disease management program had an increased prevalence of fibrosis and cirrhosis, according to a study recently published in the United European Gastroenterology Journal. To investigate the prevalence and associated risk factors of liver fibrosis and cirrhosis, Maurice Michel, MD, and colleagues assessed 175 patients with T2D in two primary care centers using vibration-controlled transient elastography. The results of a multivariable logistic regression analysis showed that harmful alcohol consumption was linked with the highest odds of cirrhosis (OR 5.615, 95% CI; 1.274-24.756, P=0.023). Alcohol was also independently associated with advanced fibrosis (OR 4.492, 95% CI; 1.367, 14.348, P=0.029). According to Dr. Michel and colleagues, screening for advanced liver disease and associated risk factors within the diabetes management program may reduce the burden of liver disease in this high-risk patient population
